QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=ED906171B1457FEE811C0F384412EFDA;jsessionid=21F11E400BB89FB601DD230477FC5317;jsessionid=DE1A1ED521CE03513F736C35A68CEB20;jsessionid=AAABBF58C007374DC5A9A6FE1BDCEE85;jsessionid=26821FF90081036BAB1BF5625D8CC4CD (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=ED906171B1457FEE811C0F384412EFDA;jsessionid=21F11E400BB89FB601DD230477FC5317;jsessionid=DE1A1ED521CE03513F736C35A68CEB20;jsessionid=AAABBF58C007374DC5A9A6FE1BDCEE85;jsessionid=26821FF90081036BAB1BF5625D8CC4CD